KA
Kamal Adawi sold $14K of FATE stock
Kamal Adawi, Chief Financial Officer of Fate Therapeutics Inc (FATE), sold 6,582 shares of FATE stock worth $14K, per an SEC Form 4 filed Nov 4, 2026.
It was an open-market sale.
The trade happened on Nov 3, 2026, 1 day before it was made public.
FATE has moved -10.0% since the trade date, from $2.04 to $1.83 (Nov 6, 2026 close).
- Traded
- Nov 3, 2026
- Disclosed
- Nov 4, 2026
- Filing delay
- 1 day
- Price since
- -10.0%
- Role
- Chief Financial Officer
- Source
- SEC Form 4